Why MDMA is a Game Changer for PTSD Treatment with Rick Doblin

oin me, Rav Arora, as I dive into an enlightening conversation with Rick Doblin, the founder of MAPS, about the transformative power of MDMA in therapeutic settings. We explore why MDMA, known for its gentle nature, is pivotal in reducing fear and enhancing feelings of love and connection, making it a breakthrough treatment for PTSD. Discover the specifics of the MDMA dosing protocol, safety concerns, and the impressive results from phase three clinical trials. We also discuss the potential approval of MDMA-assisted therapy by the FDA, the influence of the drug war on research, and the profound legacy of Roland Griffiths in psychedelic studies. This discussion sheds light on the promising future of MDMA in therapy and its broader implications for mental health treatment.

Disclaimer - This conversation was recorded in December 2023

Receive Exclusive Episodes & Q&A Content by joining our Substack Community: https://www.illusionconsensus.com/

Sponsors
- Alcami Elements :https://www.alcamielements.com/
Receive 10% OFF first order or 30% OFF subscription order using code: ILLUSION

-Brownstone institute: https://brownstone.org/

Timestamps
00:00:13 - Introduction to Rick Doblin and MAPS
00:02:30 - Choosing MDMA for Therapeutic Use
00:08:07 - The Gentle Power of MDMA
00:21:21 - Addressing Safety Concerns
00:25:59 - Dosing Protocol for MDMA-Assisted Therapy
00:36:36 - Personal Experiences and Long-Term Effects of MDMA
00:38:42 - The Self-Protective Mechanism and Therapeutic Potential of MDMA
00:47:58 - Trauma Processing and Chronic Pain Relief
01:06:16 - Promising Results from Phase Three Studies
01:20:56 - Progress and Potential Approval of MDMA-Assisted Therapy
01:37:36 - Challenges of Transparency in Research and the Influence of the Drug War
01:49:00 - The Legacy of Roland Griffiths and the Exploration of Spirituality